jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "(A) Docking of sulindac sulfide (magenta) to the LBP of RXRalpha in reference to 9-cis-RA (green). Side chains within 4A of the ligands are displayed in grey.", "sentences": [], "annotations": [], "relations": []}, {"offset": 46208, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "(B) Comparison of orientation and position of docked sulindac sulfide (magenta) to the crystal structures of 9-cis-RA (green), DHA (red) and BMS649 (blue).", "sentences": [], "annotations": [], "relations": []}, {"offset": 46364, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "(C) RXRalpha binding and inhibition of COX-1 and COX-2 activities by Sulindac analogs. RXRalpha binding was measured by competition ligand-binding assays. COX inhibition assays used Cayman's COX Fluorescent Activity Assay Kits.", "sentences": [], "annotations": [], "relations": []}, {"offset": 46592, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "(D) Inhibition of PGE2 production by Sulindac and analogs. A549 cells stimulated with TNFalpha (10 ng/ml) for 24 hr were treated with Sulindac or analogs for 30 min. PGE2 production was measured and expressed as the ratio of PGE2 produced in the presence of compound to that with vehicle. Error bars represent SEM.", "sentences": [], "annotations": [], "relations": []}, {"offset": 46907, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "(E) Comparison of 19F NMR spectra of K-80003 (100 muM) in the absence and presence of 10 muM RXRalpha LBD.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47014, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "One of three to five similar experiments is shown.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47065, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_caption"}, "text": "See also Figure S7.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47085, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_title_caption"}, "text": "K-80003 is a Potent Inhibitor of RXRalpha Dependent AKT Activation", "sentences": [], "annotations": [], "relations": []}, {"offset": 47152, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(A) Inhibition of AKT activation by Sulindac (50 muM) or K-80003 (50 muM) in the presence of TNFalpha.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47255, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(B) RXRalpha-dependent inhibition of AKT activation by K-80003. PC3 cells transfected with RXRalpha or RARgamma siRNA were pre-treated with K-80003 (50 muM) for 1 hr before exposed to TNFalpha (10 ng/ml) for 30 min. pRXRalpha: phosphorylated RXRalpha.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47507, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(C) Inhibition of RXRalpha/Delta80 interaction with p85alpha by Sulindac and K-80003. A549 cells were transfected with Flag-p85alpha and Myc-RXRalpha/Delta80, treated with Sulindac (50 muM) or K-80003 (50 muM) for 1 hr before exposed to TNFalpha for 30 min, and analyzed by co-immunoprecipitation using anti-Flag antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 47830, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(D) Induction of PARP cleavage by Sulindac or K-80003 in the presence of TNFalpha. ZR-75-1 cells treated with TNFalpha and/or Sulindac (75 muM) or K-80003 (50 muM) for 6 hr were analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 48036, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(E) Activation of caspase-8 by K-80003 in the presence of TNFalpha. Cells treated with TNFalpha and/or K-80003 (50 muM) were analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 48189, "infons": {"file": "nihms203815f8.jpg", "id": "F8", "section_type": "FIG", "type": "fig_caption"}, "text": "(F) Inhibition of clonogenic survival of RXRalpha/1-134 cells and RXRalpha/Delta80 stable clones by Sulindac (25 muM) and K-80003 (25 muM).", "sentences": [], "annotations": [], "relations": []}, {"offset": 48329, "infons": {"file": "nihms203815f8.